Foghorn Therapeutics Inc
Research Foghorn Therapeutics Inc (FHTX) on Bullrun: market cap USD 285.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFHTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 285.35M
- Financial periodFY2025
- RevenueUSD 30.91M
- Revenue growth36.8%
- Net income-USD 74.28M
- Free cash flow-USD 86.15M
Valuation Snapshot
latest market cap is USD 285.35M.
About Foghorn Therapeutics Inc
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer;
Frequently asked questions
What is Foghorn Therapeutics Inc's market cap?
Foghorn Therapeutics Inc's market capitalization is USD 285.35M.
What does Foghorn Therapeutics Inc do?
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.